???global.info.a_carregar???
Identification

Personal identification

Full name
Bibiana Ferreira

Citation names

  • Ferreira, Bibiana I.

Author identifiers

Ciência ID
A311-E925-09C5
ORCID iD
0000-0003-4772-9395

Email addresses

  • bibiana.i.ferreira@gmail.com (Professional)

Websites

  • https://www.scopus.com/authid/detail.uri?authorId=23008110200 (Scholar)
  • https://www.linkedin.com/in/bibiana-ferreira-a4133a19/ (Professional)

Knowledge fields

  • Medical and Health Sciences - Basic Medicine
  • Natural sciences - Biological Sciences - Cell Biology
  • Natural sciences - Biological Sciences - Molecular Biology
  • Medical and Health Sciences - Clinical Medicine - Oncology

Languages

Language Speaking Reading Writing Listening Peer-review
English Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Spanish; Castilian Proficiency (C2) Proficiency (C2) Advanced (C1) Proficiency (C2) Proficiency (C2)
Portuguese (Mother tongue)
Education
Degree Classification
2009/11/26
Concluded
 Biologia molecular, Bioquímica y Biomedicina (Doctor)
Universidad Autónoma de Madrid, Spain

Centro Nacional de Investigaciones Oncológicas, Spain
"ROLE OF GENOMIC INSTABILITY WITHIN THE CONTEXT OF CHROMOSOMAL REARRANGEMENTS" (THESIS/DISSERTATION)
 Summa Cum Laude
2005/06/16
Concluded
 Biologia (Licenciatura)
Universidade de Aveiro, Portugal
Affiliation

Science

Category
Host institution 		Employer
2020/09/07 - Current Principal Investigator (Research) AD-Algarve Biomedical Center, Portugal
2018/09/01 - 2020/08/31 Contracted Researcher (Research) Universidade do Algarve - Campus de Gambelas, Portugal
2015/10/01 - 2018/08/31 Postdoc (Research) Fundação para a Ciência e a Tecnologia, Portugal
2010/06/01 - 2015/07/31 Contracted Researcher (Research) Salk Institute for Biological Studies, United States

Teaching in Higher Education

Category
Host institution 		Employer
2016/10/01 - Current Invited Assistant Professor (University Teacher) Universidade do Algarve - Campus de Gambelas, Portugal

Positions / Appointments

Category
Host institution 		Employer
2020/03 - Current Organic Unit Director AD-Algarve Biomedical Center, Portugal
2018/10 - Current Cordenadora Cientifica da Unidade de Citometria Universidade do Algarve - Campus de Gambelas, Portugal

Others

Category
Host institution 		Employer
2015/01 - 2016/12 Honorary Editor BioMedWorld - Biomedworld Bioscience Limited, China
Projects

Grant

Designation Funders
2021 - Current ENDURING- Desvendar mecanismos de resistência em Glioblastoma
PTDC/MED-ONC/4167/2020-
Principal investigator
Fundação para a Ciência e a Tecnologia
2021 - Current PtCAC- ABC
72682
Principal investigator
Comissão de Coordenação e Desenvolvimento Regional do Algarve
2020 - Current Development of a new assay do detect SARS-CoV-2 directly from clinical samples
126_596760136
Researcher
Universidade do Algarve, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2017 - Current Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitors in the context of melanoma
LPCC/NRS Terry Fox 2017
Principal investigator
Liga Portuguesa Contra o Cancro
Concluded
2019 - 2021 Targeting TRIB2-mediated drug resistance in melanoma (RESIST)
RTI2018-094629-B-I00
Researcher
Ongoing
2017 - 2019 RED transfronteriza para el desarrollo de productos innovadores con microALGAs (ALGARED+)
ALGARED+
Researcher

Contract

Designation Funders
2018 - Current TRIBBLES
748585
Principal investigator
European Commission -Marie Curie
Ongoing

Other

Designation Funders
2019 - Current Using natural products from regional grapes/wine capable of regulating FOXO factors as potential anti-aging drugs
CBMR Synergy Grant 2019
Researcher
Universidade do Algarve Centro de Investigação em Biomedicina, Portugal
Ongoing
Outputs

Publications

Book chapter
  1. Henriques, Vanessa; Machado, Susana; Link, Wolfgang; Ferreira, Bibiana I.. "Monitoring the Transcriptional Activity of FOXO Transcription Factors by Analyzing their Target Genes". In Methods in Molecular Biology, 103-113. Springer New York, 2018.
    10.1007/978-1-4939-8900-3_9
  2. Machado, Susana; Raposo, Catarina; Ferreira, Bibiana I.; Link, Wolfgang. "Image-based Identification of Chemical Compounds Capable of Trapping FOXO in the Cell Nucleus". In Methods in Molecular Biology, 163-170. Springer New York, 2018.
    10.1007/978-1-4939-8900-3_14
Conference poster
  1. Ferreira, Bibiana I.. "TARGETING THE TRIB2/FOXO AXIS TO OVERCOME THERAPY RESISTANCE". Paper presented in International Symposium „Pseudokinases and Tribbles – from Molecules to Therapy”., 2020.
Journal article
  1. Pérez-Beltrán, Christian Hazael; García-Guzmán, Juan José; Ferreira, Bibiana; Estévez-Hernández, Osvaldo; López-Iglesias, David; Cubillana-Aguilera, Laura; Link, Wolfgang; et al. "One-minute and green synthesis of magnetic iron oxide nanoparticles assisted by design of experiments and high energy ultrasound: Application to biosensing and immunoprecipitation". Materials Science and Engineering: C (2021): 112023. http://dx.doi.org/10.1016/j.msec.2021.112023.
    10.1016/j.msec.2021.112023
  2. Machado, Susana; Silva, Andreia; De Sousa-Coelho, Ana Luísa; Duarte, Isabel; Grenho, Inês; Santos, Bruno; Mayoral-Varo, Victor; et al. "Harmine and Piperlongumine Revert TRIB2-Mediated Drug Resistance". Cancers 12 12 (2020): 3689. http://dx.doi.org/10.3390/cancers12123689.
    10.3390/cancers12123689
  3. Ferreira, Bibiana I.; Link, Wolfgang. "Small molecule inhibitors of CRM1". Frontiers in Pharmacology (2020):
    Accepted
  4. Jacinto, Filipe V.; Link, Wolfgang; Ferreira, Bibiana I.. "CRISPR/Cas9-mediated genome editing: From basic research to translational medicine". Journal of Cellular and Molecular Medicine (2020): http://dx.doi.org/10.1111/jcmm.14916.
    In press • 10.1111/jcmm.14916
  5. Ferreira, Bibiana I.. "Inhibition of second layer regulatory kinases differentially induces nuclear FOXO translocation". Cancer Drug Resistance (2020):
    Submitted
  6. Ferreira, Bibiana I.. "Connectivity Map-based discovery of Harmine to overcome TRIB2-mediated therapy resistance". Oncogene (2020):
    Submitted
  7. Henriques, Vanessa; Martins, Teresa; Link, Wolfgang; Ferreira, Bibiana I.. "The Emerging Therapeutic Landscape of Advanced Melanoma". Current Pharmaceutical Design 24 5 (2018): 549-558. http://dx.doi.org/10.2174/1381612824666180125093357.
    Published • 10.2174/1381612824666180125093357
  8. Hill, Richard; Madureira, Patricia A.; Ferreira, Bibiana; Baptista, Inês; Machado, Susana; Colaço, Laura; dos Santos, Marta; et al. "TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT". Nature Communications 8 1 (2017): http://dx.doi.org/10.1038/ncomms14687.
    Published • 10.1038/ncomms14687
  9. Ferreira, Bibiana I.; Lie, Maria K.; Engelsen, Agnete S. T.; Machado, Susana; Link, Wolfgang; Lorens, James B.. "Adaptive mechanisms of resistance to anti-neoplastic agents". MedChemComm 8 1 (2017): 53-66. http://dx.doi.org/10.1039/c6md00394j.
    10.1039/c6md00394j
  10. Cautain, Bastien; Castillo, Francisco; Musso, Loana; Ferreira, Bibiana I.; de Pedro, Nuria; Rodriguez Quesada, Lorena; Machado, Susana; et al. "Discovery of a Novel, Isothiazolonaphthoquinone-Based Small Molecule Activator of FOXO Nuclear-Cytoplasmic Shuttling". PLOS ONE 11 12 (2016): e0167491. http://dx.doi.org/10.1371/journal.pone.0167491.
    10.1371/journal.pone.0167491
  11. Ferreira, Bibiana I.. "Subcellular Protein Localisation in Health and Disease". eLS (2016):
    Published
  12. Ferreira, Bibiana I.; Hill, Richard; Link, Wolfgang. "Special Review: Caught in the Crosshairs: Targeted Drugs and Personalized Medicine.". The Cancer Journal 21 6 (2015): 441-447. http://dx.doi.org/10.1097/ppo.0000000000000161.
    10.1097/ppo.0000000000000161
  13. Rio-Machin, A; Ferreira, B I; Henry, T; Gómez-López, G; Agirre, X; Alvarez, S; Rodriguez-Perales, S; et al. "Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype". Leukemia 27 4 (2012): 925-931. http://dx.doi.org/10.1038/leu.2012.302.
    10.1038/leu.2012.302
  14. Rio-Machin, A.; Menezes, J.; Maiques-Diaz, A.; Agirre, X.; Ferreira, B. I.; Acquadro, F.; Rodriguez-Perales, S.; et al. "Abrogation of RUNX1 gene expression in de novo myelodysplastic syndrome with t(4;21)(q21;q22)". Haematologica 97 4 (2011): 534-537. http://dx.doi.org/10.3324/haematol.2011.050567.
    10.3324/haematol.2011.050567
  15. Sánchez-Schmidt, Júlia Ma; Salgado, Rocío; Servitje, Octavio; Gallardo, Fernando; Ortiz-Romero, Pablo L.; Karpova, Maria B.; Zipser, Marie C.; et al. "Primary Cutaneous CD30+ Anaplastic Large-Cell Lymphomas Show a Heterogeneous Genomic Profile: An Oligonucleotide ArrayCGH Approach". Journal of Investigative Dermatology 131 1 (2011): 269-271. http://dx.doi.org/10.1038/jid.2010.271.
    10.1038/jid.2010.271
  16. Di Lisio, L; Gómez-López, G; Sánchez-Beato, M; Gómez-Abad, C; Rodríguez, M E; Villuendas, R; Ferreira, B I; et al. "Mantle cell lymphoma: transcriptional regulation by microRNAs". Leukemia 24 7 (2010): 1335-1342. http://dx.doi.org/10.1038/leu.2010.91.
    10.1038/leu.2010.91
  17. Salgado, Rocío; Servitje, Octavio; Gallardo, Fernando; Vermeer, Maarten H.; Ortiz-Romero, Pablo L.; Karpova, Maria B.; Zipser, Marie C.; et al. "Oligonucleotide Array-CGH Identifies Genomic Subgroups and Prognostic Markers for Tumor Stage Mycosis Fungoides". Journal of Investigative Dermatology 130 4 (2010): 1126-1135. http://dx.doi.org/10.1038/jid.2009.306.
    10.1038/jid.2009.306
  18. Marcos, Nuno T.; Magalhães, Ana; Ferreira, Bibiana; Oliveira, Maria J.; Carvalho, Ana S.; Mendes, Nuno; Gilmartin, Tim; et al. "Helicobacter pylori induces ß3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl–Lewis x". Journal of Clinical Investigation (2008): http://dx.doi.org/10.1172/jci34324.
    10.1172/jci34324
  19. Ferreira, B. I.; Garcia, J. F.; Suela, J.; Mollejo, M.; Camacho, F. I.; Carro, A.; Montes, S.; Piris, M. A.; Cigudosa, J. C.. "Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia". Haematologica 93 5 (2008): 670-679. http://dx.doi.org/10.3324/haematol.12221.
    10.3324/haematol.12221
  20. Ferreira, B I; Alonso, J; Carrillo, J; Acquadro, F; Largo, C; Suela, J; Teixeira, M R; et al. "Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma". Oncogene 27 14 (2007): 2084-2090. http://dx.doi.org/10.1038/sj.onc.1210845.
    10.1038/sj.onc.1210845
  21. Largo, C.; Saez, B.; Alvarez, S.; Suela, J.; Ferreira, B.; Blesa, D.; Prosper, F.; Calasanz, M. J.; Cigudosa, J. C.. "Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations". Haematologica 92 6 (2007): 795-802. http://dx.doi.org/10.3324/haematol.11052.
    10.3324/haematol.11052
  22. Pinho, Sandra; Marcos, Nuno T.; Ferreira, Bibiana; Carvalho, Ana S.; Oliveira, Maria J.; Santos-Silva, Filipe; Harduin-Lepers, Anne; Reis, Celso A.. "Biological significance of cancer-associated sialyl-Tn antigen: Modulation of malignant phenotype in gastric carcinoma cells". Cancer Letters 249 2 (2007): 157-170. http://dx.doi.org/10.1016/j.canlet.2006.08.010.
    10.1016/j.canlet.2006.08.010
  23. Suela, J; Álvarez, S; Cifuentes, F; Largo, C; Ferreira, B I; Blesa, D; Ardanaz, M; et al. "DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups". Leukemia 21 6 (2007): 1224-1231. http://dx.doi.org/10.1038/sj.leu.2404653.
    10.1038/sj.leu.2404653
  24. Suela, Javier; Largo, Cristina; Ferreira, Bibiana; Álvarez, Sara; Robledo, Mercedes; González-Neira, Anna; Calasanz, Maria José; Cigudosa, Juan C.. "Neurofibromatosis 1, and Not TP53, Seems to Be the Main Target of Chromosome 17 Deletions in De Novo Acute Myeloid Leukemia". Journal of Clinical Oncology 25 9 (2007): 1151-1152. http://dx.doi.org/10.1200/jco.2006.09.3013.
    10.1200/jco.2006.09.3013
  25. Ferreira, Bibiana; Marcos, Nuno T.; David, Leonor; Nakayama, Jun; Reis, Celso A.. "Terminal a1,4-linked N-acetylglucosamine in Helicobacter pylori-associated Intestinal Metaplasia of the Human Stomach and Gastric Carcinoma Cell Lines". Journal of Histochemistry & Cytochemistry 54 5 (2006): 585-591. http://dx.doi.org/10.1369/jhc.5a6836.2006.
    10.1369/jhc.5a6836.2006
Thesis / Dissertation
  1. Ferreira, Bibiana; Silva, Elisabete Cruz da. "Integrin alpha5beta1 and resistance to cancer therapies: role of endocytosis in resistance to gefitinib". Master, 2017. http://hdl.handle.net/10400.1/9975.
  2. Link, Wolfgang; Ferreira, Bibiana; Henriques, Vanessa Mendes. "Characterization of TRIB2-mediated resistance to pharmacological inhibition of MEK". Master, 2017. http://hdl.handle.net/10400.1/10705.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2019/02 Discovering drugs to overcome anti-cancer drug resistance Challenging organic synthesis inspired by nature - from natural products chemistry to drug discovery, COST action-CM1407
2016/07 Melanoma is in TRIBBLES 1st CBMR/ProRegeM Annual Meeting
2016/06 A CRISPR view on TRIBBLES proteins Tribbles Proteins at the Interface of Metabolism and Cancer
2016/04 Characterization of TRIB2-mediated resistance to anti-melanoma drugs Jornadas de Investigação em Oncologia em Portugal
2008/09 Patterns of Genomic Instability associated with cell cycle and DNA repair in Ewing sarcomas – gene expression and aCGH profiling 11th European Workshop on Cytogenetics and Molecular Genetics of Solid Tumours (11th EWCMGST)
2007/05 MOLECULAR PROFILING OF THE GENOME MC-GARD Conference
2006/09 t(11;22) Ewing sarcomas genomic characterization by high resolution CGH array reveals distinct subgroups 3rd Marie Curie Conference on array CGH and molecular cytogenetics

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2019 - Current Studying the role of hypoxia in glioblastoma
Co-supervisor
 Oncobiologia - Mecanismos Moleculares do Cancro (Master)
Universidade do Algarve, Portugal
2019 - Current Generation of drug resistant cell lines as a model to study melanoma, pancreatic cancer and glioblastoma
Supervisor
2019 - Current Characterizing the role of FOXO regulators and FOXO isoforms in cancer
Supervisor
 Ciências Biomédicas (PhD)
Universidade do Algarve, Portugal
2016 - Current Integrin alpha5beta1 and resistance to cancer therapies: Role of endocytosis in resistance to gefitinib
Co-supervisor
 Oncobiologia - Mecanismos Moleculares do Cancro (Master)
Universidade do Algarve, Portugal
2016 - Current Characterization of TRIB2 mediated drug resistance and its validation as a novel diagnostic marker
Co-supervisor
 ProREGEM (PhD)
2019 - 2019 Study of a panel of inhibitors on TRIB2 –AKT association by Protein Complementation Assay
Supervisor
 Mestrado Integrado em Medicina (Other)
2018 - 2019 Study of the TRIB2 protein network
Supervisor
 Oncobiologia - Mecanismos Moleculares do Cancro (Master)
Universidade do Algarve, Portugal
2018 - 2019 Efeito de diferentes terapêuticas citotóxicas na expressão do CD133, Wnt/ß-catenina no cancro do colo do útero
Co-supervisor
 Oncobiologia - Mecanismos Moleculares do Cancro (Master)
Universidade do Algarve, Portugal
2018 - 2018 CRISPR/Cas9-mediated genome editing: from basic research to translational medicine
Supervisor
 Mestrado Integrado em Medicina (Other)
2017 - 2018 CRISPR: Appplications in Human pathologies and future prospects
Co-supervisor
 Ciências Farmacêuticas (Master)
Universidade do Algarve Faculdade de Ciências e Tecnologia, Portugal
2016 - 2017 Characterization of TRIB2-mediated resistance to pharmacological inhibition of MEK
Co-supervisor
 Oncobiologia - Mecanismos Moleculares do Cancro (Master)
Universidade do Algarve, Portugal
2016 - 2016 Generating Cellular Models to Unravel the Oncogenic Properties of TRIB2 in Melanoma Cells Using the CRISPR-Cas9 System
Supervisor
 mestrado integrado em medicina (Other)
Universidade do Algarve Departamento de Ciências Biomédicas e Medicina, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2020/03/30 - Current Coordinator of the "COVID19 Testing Unit" at ABC. Responsible for the implementation of the COVID19 diagnostic lab at the Universidade do Algarve. (2020)
Other
 Universidade do Algarve, Portugal
2020/02 - Current MIcromundo- Programa de sensibilizaçao do uso de antibioticos na populaçao a longo prazo. https://tinyearth.wisc.edu/ (2020/02)
Other (Member of the Organising Committee)
 Universidade do Algarve - Campus de Gambelas, Portugal
2020/01/30 - 2020/01/31 2nd Joint COST-WG4-WG5 TRANSAUTOPHAGY Translational Workshop (2020/01/30 - 2020/01/31)
Congress
 Universidade do Algarve Centro de Investigação em Biomedicina, Portugal
2020/01 - 2020/01 INTERNATIONAL MEETING OF THE PORTUGUESE SOCIETY OF GENETICS (2020/01/23 - 2020/01/24)
Congress (Member of the Organising Committee)
 Universidade do Algarve - Campus de Gambelas, Portugal
2019/11/25 - 2019/11/27 Flow Cytometry Course - CBMR Training Program (2019/11/25 - 2019/11/27)
Workshop (Co-organisor)
 Universidade do Algarve Centro de Investigação em Biomedicina, Portugal
2008/03/10 - 2008/03/11 CNIO ONCOTRAIN Workshop: “New Battlefields in Cancer- Attacking in Many Fronts (2008/03)
Conference
 Centro Nacional de Investigaciones Oncológicas, Spain

Event participation

Activity description
Type of event 		Event name
Institution / Organization
2020/05/05 - 2020/05/08 Laboratory Leadership for Group Leaders: Leadership and management skills are critical for a successful career in science. This course has been designed to meet the specific needs of researchers progression into an independent position.
Workshop
 Laboratory Leadership for Group Leaders
2019/06/05 - 2019/06/07 Workshop on Genome Editing using CRISPR-Cas9: The aim of this workshop is to provide hands-on training in genome editing in mammalian cells using the powerful CRISPR/Cas9 system. It will cover topics from sgRNA design, molecular cloning and transfection, through off-target assessment, validation and different applications.
Workshop
 Workshop on Genome Editing using CRISPR-Cas9
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2013 - 2013 Modern Marketing for Scientists: “How to Sell Yourself and Your Work” (Marc Kuchner)
Salk Institute for Biological Studies, United States
2005 - 2005 Workshop on molecular biology and cellular of cancer – Introduction to the cellular and molecular mechanisms

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2019 Avaliação da expressão de PD-L1 e de subpopulações linfocitárias em Cancro da mama
(Thesis) Main arguer
 Cátia Neto (Master)
Universidade do Algarve, Portugal
2019 MAGNETIC NANOPARTICLES FOR BIOSENSING AND IMMUNOPRECIPITATION
(Thesis) Main arguer
 Christian Perez (Master)
2019  Study of the TRIB2 protein network 
Supervisor
 Catarina Raposo (Master)
2017 Analysis of transcriptional and post- transcriptional regulators of DUSP4, a human gene associated with CRC
(Thesis) Main arguer
 Tatiana Varela (Master)
Universidade do Algarve Faculdade de Ciências e Tecnologia, Portugal
2017 Nanoparticulas de ouro no tratamento do cancro da mama
(Thesis) Main arguer
 Raquel Marques (Master)
Universidade do Algarve Faculdade de Ciências e Tecnologia, Portugal
2017 Integrin alpha5beta1 and resistance to cancer therapies: Role of endocytosis in resistance to gefitinib
Supervisor
 Elisabete Cruz da SILVA (Master)
Universidade do Algarve, Portugal
2017 Characterization of TRIB2-mediated resistance to pharmacological inhibition of MEK
Supervisor
 Vanessa Henriques (Master)
2016 Contribuição para a identificação do papel da MGP no desenvolvimento tumoral no cancro colorretal
(Thesis) Main arguer
 Inês Martins Silva (Master)
Universidade do Algarve Faculdade de Ciências e Tecnologia, Portugal

Association member

Society Organization name Role
2015 - Current Associaçao Portuguesa de Investigação em Cancro

Committee member

Activity description
Role 		Institution / Organization
2020/01 - Current Member of the Executive board of the Portuguese Society of Genetics
Member
 Portuguese Society of Genetics, Portugal

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2016/09 - Current Progressão Tumoral Oncobiologia- Mecanismos Moleculares do Cancro (Mestrado) Universidade do Algarve - Campus de Gambelas, Portugal
2019/10/03 - 2019/10/03 Seminar: "Keep your cells CRISPr" Ciências Biomédicas (Licenciatura) Universidade de Aveiro, Portugal
2008 - 2010 Identificación de alteraciones en el genoma utilizando array-CGH (Master) Centro Nacional de Investigaciones Oncológicas, Spain

Interview (tv / radio show)

Program Topic
2021/02/11 - Current TSF- igualdade de genero Mulheres na ciência: muitas habilitações e ainda sem estabilidade na vida

Journal scientific committee

Journal title (ISSN) Publisher
2017/06 - Current Scientific Reports (2045-2322) Springer Science and Business Media LLC
Distinctions

Other distinction

2017 LPCC-Terry Fox
2017 MCSC- Marie Curie Re-Integration Fellowship
2014 Bolsa de Post-Doutoramento
2005 Bolsa de Doutoramento- ONCOTRAIN Program - Marie Curie Early Stage Researcher MEST-CT-2005-6423